Close Menu
    Facebook X (Twitter) Instagram
    SciTechDaily
    • Biology
    • Chemistry
    • Earth
    • Health
    • Physics
    • Science
    • Space
    • Technology
    Facebook X (Twitter) Pinterest YouTube RSS
    SciTechDaily
    Home»Biology»Yale Study Shows Topical Ruxolitinib Grows Hair
    Biology

    Yale Study Shows Topical Ruxolitinib Grows Hair

    By Ziba Kashef, Yale UniversityDecember 9, 20157 Comments3 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn WhatsApp Email Reddit
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email Reddit
    Topical Ruxolitinib Helps Teen Grow Hair
    The topical application of an oral medication, typically used for treating bone marrow diseases, has shown potential for promoting hair growth.

    A new study from Yale University reveals that a topical formulation of an oral medication used to treat bone marrow diseases can be used to grow hair.

    A young woman who had no scalp or eyebrow hair for years now enjoys a full mane after using a novel cream devised by researchers at Yale School of Medicine.

    The 17-year-old patient suffered from alopecia areata, a disfiguring autoimmune disease that affects tens of millions of people worldwide and has limited treatment options. Alopecia areata may cause spotty hair loss or complete loss of scalp hair, eyebrows, eyelashes, and all other body hair. The patient in this study, published December 9 in JAMA Dermatology, had tried multiple treatments with no success.

    To treat the condition, Dr. Brett King, assistant professor of dermatology, and his co-authors, Dr. Brittany Craiglow and Daniel Tavares, devised a topical formulation of an oral medication used to treat bone marrow diseases.

    Yale Study Shows Novel Cream Grows Hair
    After 12 weeks of treatment at Yale, the patient had complete restoration of eyebrow hair. (Photos by Dr. Brett King)

    The drug, ruxolitinib, belongs to a class of medications called JAK inhibitors, which alter the immune system. King had previously used another oral JAK inhibitor, tofacitinib, to restore hair to a male patient with alopecia universalis in 2014, and other researchers have shown that oral ruxolitinib restores hair in this condition, too.

    For this study, the patient applied the cream twice a day to the scalp and eyebrows. After 12 weeks, she had complete restoration of eyebrows and partial regrowth of her scalp. After switching from the cream to a pill form to continue her treatment, the patient now has a full head of hair.

    The outcome was better than anticipated, said King. “The results with the cream are as good as what is expected with pills over the same amount of time,” he noted. “The results are remarkable.”

    A cream is more appropriate for many patients with alopecia areata, including those concerned about possible risks, such as cancer or infections, that have been associated with oral JAK inhibitors, said the researchers. No side effects were observed in the patient using the cream.

    “This is a first in the treatment of a devastating and common autoimmune disease and builds on our recent efforts to show that treatment is within reach for millions of people who suffer from alopecia areata and will hopefully continue to build interest in finding solutions for this and other autoimmune diseases,” said King.

    Reference: “Topical Ruxolitinib for the Treatment of Alopecia Universalis” by Brittany G. Craiglow, MD; Daniel Tavares, PharmD and Brett A. King, MD, Ph.D., December 9, 2015, JAMA Dermatol.
    DOI: 10.1001/jamadermatol.2015.4445

    Never miss a breakthrough: Join the SciTechDaily newsletter.
    Follow us on Google and Google News.

    Dermatology Disease Hair Medicine Yale University
    Share. Facebook Twitter Pinterest LinkedIn Email Reddit

    Related Articles

    VPS13 Proteins Role in Neurological Disorders, Including Parkinson’s

    New Test for Alzheimer’s Disease Directly Measures Synaptic Loss

    Biologists Develop Breakthrough RNA-Based Therapy to Target West Nile Virus

    New Study Shows Absence of ANGPTL4 Protein Reduces Cholesterol and Inflammation

    New Study Reveals How Gut Bacteria Drive Autoimmune Disease

    A Possible New Treatment for Baldness, Regulatory T Cells Facilitate Hair Growth

    Yale Research Provides New Clues to How Cancer Cells Spread

    Yale Researchers Identify RNA That Controls Cholesterol

    FDA Approved Arthritis Drug Spurs Hair Growth

    7 Comments

    1. Madanagopal.V.C. on December 10, 2015 9:10 am

      Alopacea areata beardae can be treated by using salt and lemon juice over the area and rubbing it hard. Here the hair growth will be sooner and otherwise if we leave it without treatment they will grow again say in a year’s time. The hair cells roots which got retarded (but not destroyed)will be awakened by this procedure. But this treatment is not recommended for Alopacea areata totallis. The article talks of a cream which may work but it is to be established well . The reason is the candidates available will be less to test and study this. Thank You.

      Reply
    2. Alopecia on December 13, 2015 10:36 pm

      WE ALL NEED THIS -NOW-! Pretty much most Alopecia sufferers would do anything for this, so why isn’t it readily available?

      Reply
    3. Ramana on January 25, 2016 6:32 am

      If it is true,why it is not available to millions of people

      Reply
    4. Andy on August 14, 2016 3:15 pm

      As others are eluding to, when will this be available? Are further trials being conducted, including other types of alopecia? Namely congenital triangular alopecia (or temporal triangular alopecia). If this is indeed effective it needs to be available asap at a reasonable price

      Reply
    5. Theresa on January 10, 2017 6:50 am

      My skin conditions are eczema and icthyosis. In spite of my skin conditions I’ve always had a full head of healthy long hair until about one and a half years ago. I’m horrified! Are further trials being conducted in Kansas City, Missouri inclusive of Alopecia Areata? Where is this miracle topical cream available?

      Reply
    6. Lana Atkinson on July 19, 2017 12:29 pm

      I would like to participate in your research. I’m a 70 year old female in Nashville TN. I still work and sing but my hair is getting embarrassingly thin. Let me be one of your ginny pigs. I would like to help you and help me!

      Reply
    7. Hayko Klett on May 15, 2018 2:29 pm

      I AM 80 YEARS OLD AND HAVE USEDCLOBETASOL TOPICAL SOLUTION WITH LIMITED
      RESULT AND WOULD BE HAPPY TO GIVE RUXOLITINIB TOPICAL CREAM A TRY OUT.

      Reply
    Leave A Reply Cancel Reply

    • Facebook
    • Twitter
    • Pinterest
    • YouTube

    Don't Miss a Discovery

    Subscribe for the Latest in Science & Tech!

    Trending News

    Bone-Strengthening Discovery Could Reverse Osteoporosis

    Scientists Uncover Hidden Trigger Behind Stem Cell Aging

    Scientists Find Way to Reverse Fatty Liver Disease Without Changing Diet

    Could Humans Regrow Limbs? New Study Reveals Promising Genetic Pathway

    Scientists Reveal Eating Fruits and Vegetables May Increase Your Risk of Lung Cancer

    Scientists Reverse Brain Aging With Simple Nasal Spray

    Scientists Uncover Potential Brain Risks of Popular Fish Oil Supplements

    Scientists Discover a Surprising Way To Make Bread Healthier and More Nutritious

    Follow SciTechDaily
    • Facebook
    • Twitter
    • YouTube
    • Pinterest
    • Newsletter
    • RSS
    SciTech News
    • Biology News
    • Chemistry News
    • Earth News
    • Health News
    • Physics News
    • Science News
    • Space News
    • Technology News
    Recent Posts
    • Scientists Decode Mysterious Magnetic “Maze Domains” To Boost EV Efficiency
    • Scientists Say This Fungus Could Survive the Trip to Mars
    • The Universe Is Expanding Too Fast and Scientists Can’t Explain Why
    • Gaining Weight Young May Be More Dangerous Than You Think
    • Scientists Discover Hidden Pathway Inside Catalysts That Defies Decades of Assumptions
    Copyright © 1998 - 2026 SciTechDaily. All Rights Reserved.
    • Science News
    • About
    • Contact
    • Editorial Board
    • Privacy Policy
    • Terms of Use

    Type above and press Enter to search. Press Esc to cancel.